4//SEC Filing
Tokman Alexander Y 4
Accession 0001209191-20-024217
CIK 0001681682other
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 4:46 PM ET
Size
5.2 KB
Accession
0001209191-20-024217
Insider Transaction Report
Form 4
Tokman Alexander Y
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2020-04-09+42,857→ 42,857 total
Footnotes (2)
- [F1]Represents restricted stock units granted in lieu of the Reporting Person's cash retainer payable under the Issuer's Non-Employee Director Compensation Policy for the second, third and fourth quarters of 2020. The restricted stock units vest in three equal installments on the last day of each such calendar quarter. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Includes unvested restricted stock units.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeother
Related Parties
1- filerCIK 0001334483
Filing Metadata
- Form type
- 4
- Filed
- Apr 12, 8:00 PM ET
- Accepted
- Apr 13, 4:46 PM ET
- Size
- 5.2 KB